Compounds > fluoromisonidazole
Page last updated: 2024-08-26

fluoromisonidazole and Nasopharyngeal Neoplasms

fluoromisonidazole has been researched along with Nasopharyngeal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, YM; Kuge, Y; Nishikawa, Y; Okamoto, S; Onimaru, R; Peng, H; Shiga, T; Shirato, H; Takeuchi, W; Tamaki, N; Tsuchiya, K; Watanabe, S; Yasuda, K1
Fu, M; Lv, B; Qiu, J; Wang, X; Zheng, X; Zhuo, W1
Katoh, N; Kuge, Y; Okamoto, S; Onimaru, R; Shiga, T; Shirato, H; Suzuki, R; Takeuchi, W; Tamaki, N; Tsuchiya, K; Yasuda, K1
Chang, CW; Chen, KY; Chou, KL; Liu, RS; Wu, LC; Yang, DJ; Yeh, SH; Yen, SH; Yu, TW1
Chang, CP; Chang, CW; Chen, KY; Chou, KL; Chu, LS; Liu, RS; Lui, MT; Wu, LC; Yeh, SH; Yen, SH1

Other Studies

5 other study(ies) available for fluoromisonidazole and Nasopharyngeal Neoplasms

ArticleYear
Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
    Radiation oncology (London, England), 2017, Sep-06, Volume: 12, Issue:1

    Topics: Adult; Aged; Carcinoma; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated

2017
    Head & neck, 2017, Volume: 39, Issue:12

    Topics: Adult; Carcinoma; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Sampling Studies; Treatment Outcome; Tumor Burden

2017
[18F]fluoromisonidazole and a new PET system with semiconductor detectors and a depth of interaction system for intensity modulated radiation therapy for nasopharyngeal cancer.
    International journal of radiation oncology, biology, physics, 2013, Jan-01, Volume: 85, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Brain Neoplasms; Case-Control Studies; Cell Hypoxia; Female; Humans; Laryngeal Neoplasms; Lutetium; Male; Middle Aged; Misonidazole; Mouth Neoplasms; Multimodal Imaging; Nasopharyngeal Neoplasms; Nasopharynx; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Semiconductors; Silicates; Thyroid Neoplasms; Tomography, X-Ray Computed

2013
Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:10

    Topics: Carcinoma; Case-Control Studies; Cell Hypoxia; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Misonidazole; Nasopharyngeal Neoplasms; Nasopharynx; Neck Muscles; Radiation-Sensitizing Agents; Tomography, Emission-Computed

1996
Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:10

    Topics: Bacteria, Anaerobic; Bacterial Infections; Carcinoma; Case-Control Studies; Cell Hypoxia; Dental Caries; Dental Pulp Diseases; Fluorine Radioisotopes; Humans; Misonidazole; Nasopharyngeal Neoplasms; Periodontal Diseases; Predictive Value of Tests; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tomography, Emission-Computed

1996